PO.CL05.05 · 临床研究
Immunomodulatory Effects of Targeted Therapies
-
-
-
-
-
-
-
-
-
-
- 2569 2569 粒子治疗、ATM和PD-1抑制用于pMMR直肠癌 Particle therapy, ATM and PD-1 inhibition for pMMR rectal cancer Cameron M. Callaghan
-
-
-
-
-
- 2576 2576 靶向肠道的抗生素调节增强NSCLC的放疗反应,并揭示驱动活体生物治疗药物设计的表观遗传及微生物组驱动的免疫程序 Gut-targeted antibiotic modulation enhances radiotherapy response in NSCLC and uncovers epigenetic and microbiome-driven immune programs enabling live biotherapeutic design Steven J. Feigenberg, Francesca Costabile, Ceylan Tanses, Kyle Bittinger, Divyansh Agarwal, Roddy O'Connor, Jeffrey Bradley, Amit Maity, Benjamin A. Garcia, Andrea Facciabene
- 2577 2577 游离型和包裹型衣霉素通过阻断K-Ras G12D表达,显著增强吉西他滨对胰腺导管腺癌细胞中PD-L1的抑制 Free and encapsulated tunicamycin significantly enhances the suppression of PD-L1 by gemcitabine through blocking K-Ras G12D expression in pancreatic ductal adenocarcinoma cells Axel Hugo Breier, Sunil P. Upadhyay, Ojaswitha Ommi, Stefan Bossmann, Sushanta K. Banerjee, Snigdha Banerjee
-
-
